Skip to content

Veracyte VCYT Accrued Expenses

Accrued Expenses at other companies

Guardant Health logo
Guardant HealthGH
$78.01M+2.6%
Natera, Inc. logo
Natera, Inc.NTRA
$143.81M+205%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$148.4M-5.7%
Revvity logo
RevvityRVTY
$10.7M-10.1%
Labcorp Holdings logo
Labcorp HoldingsLH
$851.9M+10.6%
Agilent Technologies logo
Agilent TechnologiesA
$298M-20.3%

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.29B+10.7%

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veracyte's accrued expenses?
Veracyte (VCYT) reported accrued expenses of $18.94M in Q1 2026.
How has Veracyte's accrued expenses changed year-over-year?
Veracyte's accrued expenses increased by 1.3% year-over-year, from $18.7M to $18.94M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.